Folate and vitamin B6 rapidly normalize endothelial dysfunction in children with type 1 diabetes mellitus

Karen E MacKenzie1, Esko J Wiltshire, Roger Gent

  • 1Department of Diabetes and Endocrinology, Children, Youth, and Women's Health Service, Adelaide, Australia. karen.mackenzie@adelaide.edu.au

Pediatrics
|July 5, 2006
PubMed

Insights

High-dose folate and vitamin B6 significantly improved endothelial dysfunction in children with type 1 diabetes, with effects sustained for 8 weeks. These vitamins normalized vascular function, independent of other metabolic markers.

Area of Science:

  • Vascular Biology
  • Pediatric Endocrinology
  • Nutritional Science

Background:

  • Endothelial dysfunction is an early complication in type 1 diabetes mellitus, preceding overt vascular disease.
  • Folate status is implicated in the development of endothelial dysfunction in diabetic patients.

Purpose of the Study:

  • To investigate the effects of high-dose folate and vitamin B6 on endothelial function in children with type 1 diabetes.
  • To determine the immediate and sustained effects of folate and vitamin B6, alone and in combination, on vascular health.

Main Methods:

  • A randomized, double-blind, placebo-controlled trial involving 124 children with type 1 diabetes.
  • Vitamins (folate 5 mg/day, vitamin B6 100 mg/day) were administered alone or combined, with endothelial function assessed via brachial artery ultrasound (flow-mediated and glyceryltrinitrate-induced dilation).
  • Measurements were taken at baseline, 2-4 hours post-dose, and at 4 and 8 weeks of treatment.

Main Results:

  • Flow-mediated dilation (FMD) normalized in all treatment groups, improving significantly from baseline to 8 weeks with folate, vitamin B6, and combination therapy.
  • Improvements in FMD were observed within 2 hours and maintained for 8 weeks; placebo and glyceryltrinitrate-induced dilation showed no significant changes.
  • Increased serum folate, red cell folate, and vitamin B6 levels correlated with FMD improvements, independent of homocysteine, glucose, HbA1c, or CRP levels.

Conclusions:

  • High-dose folate and vitamin B6 effectively normalized endothelial dysfunction in children with type 1 diabetes.
  • The positive effects on endothelial function were sustained over 8 weeks.
  • Combination therapy offered no additional benefit over monotherapy with either folate or vitamin B6.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...